Clinical Trials for Criterium

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Criterium

Clinical Trials (6)

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

PHASE2Not yet recruiting

120 participants

Started: Sep 15, 2025 · Completed: Dec 31, 2028

1 condition1 sponsor0 locations

Tucatinib+Trastuzumab+Eribulin in HER2+ MBC

PHASE2Recruiting

30 participants

Started: Jan 30, 2024 · Completed: Aug 1, 2027

2 conditions1 sponsor6 locations

Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.

PHASE1/PHASE2Recruiting

40 participants

Started: Aug 25, 2022 · Completed: Jun 30, 2025

1 condition3 sponsors4 locations

A Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer

PHASE2Active, not recruiting

48 participants

Started: Jul 28, 2022 · Completed: Mar 1, 2026

1 condition6 sponsors4 locations

Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

PHASE2Active, not recruiting

48 participants

Started: Jun 23, 2021 · Completed: Feb 9, 2026

7 conditions5 sponsors5 locations

DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)

PHASE2Recruiting

70 participants

Started: Feb 9, 2021 · Completed: Dec 31, 2028

1 condition1 sponsor19 locations